Variations in the levels of KIM-1 and β2MG in SLE patients correlate with the severity of the disease, the presence of tissue lesions (including renal, hematological, and cutaneous lesions), and the extent of inflammation. The gene discussed is HAVCR1; the disease is systemic lupus erythematosus.